Abu Dhabi, May 7 -- In a significant step towards revolutionizing the diagnostic landscape in the region, Burjeel Holdings has commissioned a cutting-edge, advanced molecular diagnostics and immune profile testing laboratory in the UAE. To manage the technical and operational aspects, the Group's central laboratory - CoLab - has partnered with Canada-based OncoHelix that provides specialized molecular and immune profile testing for clinical diagnostic, and translational research in North America and around the world. Located at Burjeel Holdings' flagship facility, Burjeel Medical City ("BMC"), OncoHelix-CoLab is a first-of-its-kind facility in the UAE with comprehensive capabilities in molecular, cellular immunology and transplant diagnosti...